Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 118 Neoplasms 110 Lung Neoplasms 65 Colorectal Neoplasms 52 Prostatic Neoplasms 46 Carcinoma, Non-Small-Cell Lung 46 Pancreatic Neoplasms 34 Melanoma 33 Ovarian Neoplasms 29 Neoplastic Cells, Circulating 29 Head and Neck Neoplasms 27 Uterine Cervical Neoplasms 23 Multiple Myeloma 20 Glioma 20 Colonic Neoplasms 20 Sarcoma 19 Carcinoma, Hepatocellular 19 Leukemia, Myeloid, Acute 18 Neoplasm Metastasis 17 Lymphoma 15 Glioblastoma 15 Esophageal Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Hematologic Neoplasms 14 Leukemia 13 Endometrial Neoplasms 13 Myelodysplastic Syndromes 11 Kidney Neoplasms 11 Gastrointestinal Neoplasms 11 Carcinoma, Renal Cell 11

Interventions

Doxorubicin 25 Gemcitabine 16 Trabectedin 12 Ifosfamide 12 Radiotherapy 11 Docetaxel 10 Dacarbazine 8 pazopanib 7 Nivolumab 6 Specimen Handling 5 Biopsy 5 liposomal doxorubicin 4 Temozolomide 4 pembrolizumab 3 Sunitinib 3 Sorafenib 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 rucaparib 2 pegfilgrastim 2 olaratumab 2 eribulin 2 durvalumab 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Blood Specimen Collection × Clear all

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡